Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: GlobeNewswire
SAINT PAUL, Minn., April 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. announce that the United States District Court District of Minnesota has approved the following announcement of a proposed class action settlement that would benefit purchasers of Lifecore Biomedical, Inc. Securities (NASDAQ: LFCR): UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA DAVID CAREW, Individually and on Behalf of All Others Similarly Situated,Plaintiff,v.LIFECORE BIOMEDICAL, INC., ALBERT D. BOLLES, JAMES G. HALL, BRIAN MCLAUGHLIN, and JOHN MORBERG,Defendants. No. 0:24-cv-03028-LMP-EMBCLASS ACTIONSUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF CLASS ACTION AND MOTION FOR ATTORNEYS’ FEES, REIMBURSEMENT OF EXPENSES, AND AWARDS TO LEAD PLAINTIFFS To: All persons and entities that purchased or otherwise acquired Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) securities between October 7, 2020, and March 19, 2024, both dates inclusive (the “Settlement Class Period”)
Show less
Read more
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? [Yahoo! Finance]Yahoo! Finance
- Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical CustomerGlobeNewswire
- Lifecore Biomedical (LFCR) had its "outperform" rating reaffirmed by Barrington Research. They now have a $5.50 price target on the stock.MarketBeat